Viewing Study NCT02097303


Ignite Creation Date: 2025-12-24 @ 7:12 PM
Ignite Modification Date: 2026-02-09 @ 9:02 AM
Study NCT ID: NCT02097303
Status: COMPLETED
Last Update Posted: 2018-02-01
First Post: 2014-03-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis
Sponsor: Carolina Research Professionals, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prostate Cancer View
None Bone Metastasis View
None Symptomatic View
None Androgen Independent View
None Hormone Refractory View
None Castrate Resistant View
None AIPC View
None pre-chemotherapy View
None Post-chemotherapy View